The Latest Breaking News from WST

West Pharmaceutical Services Inc (NYSE:WST) reported first-quarter FY22 sales growth of 7.4% year-on-year to $720 million, missing the consensus of $720.92 million. Proprietary products segment revenue grew 10.6% Y/Y to $601.3 million. Contact-manufactured products segment sales declined 6.6% to $118.7 million. Gross profit margin fell 100 basis points to 40%, and the gross…

  West Pharmaceutical Servs (NYSE:WST) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Major benchmark stock indexes have been hit hard this month on concerns over high inflation and the Fed’s decision to raise interest rates. However, following fourth-quarter GDP growth, a promising economic outlook should help growth-focused companies perform well this year. Therefore, we think it could be wise to bet on…

A growing demand for early medical diagnosis is driving the market for advanced medical equipment by healthcare centers and hospitals. Also, increasing spending on research & development by medical technology companies to deliver innovative technology is helping the industry rebound. So, we think the recent price dips in the stocks…